Beleaguered financial institution AMP is facing yet another shareholder class action with Shine Lawyers joining three other law firms in what is shaping up to be a beauty pageant of class actions.
DLA Piper’s patent advice to Neurim not privileged, court hears
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company’s founder and her lawyers from DLA Piper.
Unique slams ACCC’s ‘paucity’ of evidence in appeal hearing
ASIC vows to use ‘every inch’ of power to go after corporate violators
ACCC flags concerns over Transurban bid for WestConnex
Telstra wins temporary block on Optus ‘Empires End’ ad
Blackmail case dropped against CFMEU bosses John Setka, Shaun Reardon
Radio Rentals to pay $2M following ASIC probe
Aerocare loses Federal Court appeal over workplace agreement
Quinn Emanuel AMP financing heralds era of class action beauty pageants
The financing arrangement underwriting Quinn Emanuel’s shareholder class action against AMP, which will earn its partner Burford Capital a record low 10 percent of any recovery, sets a new standard in class action litigation funding, and is expected to spark greater price competition in the industry.